Cargando…

Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis

Mounting evidence suggests that microbiota dysbiosis caused by antibiotic administration is a risk factor for cancer, but few research reports focus on the relationships between antibiotics and chemotherapy efficiency. We evaluated the influence of antibiotic administration on neoadjuvant therapy ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xi, Yu, Long, Shi, Jiajie, Li, Sainan, Yang, Shiwei, Gao, Wei, Yang, Shan, Cheng, Meng, Wang, Haoqi, Guo, Zhanjun, Geng, Cuizhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263554/ https://www.ncbi.nlm.nih.gov/pubmed/34234229 http://dx.doi.org/10.1038/s41598-021-93428-w

Ejemplares similares

Role of PAX2 in breast cancer verified by bioinformatics analysis and in vitro validation
por: Yang, Shan, et al.
Publicado: (2023)

Effect of gastrointestinal microbiome and its diversity on the expression of tumor-infiltrating lymphocytes in breast cancer
por: Shi, Jiajie, et al.
Publicado: (2019)

Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis
por: Zhang, Wenshan, et al.
Publicado: (2022)

Author Correction: Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis
por: Zhang, Wenshan, et al.
Publicado: (2022)

HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study
por: Shi, Jiajie, et al.
Publicado: (2023)

Assisted computer and imaging system improve accuracy of breast tumor size assessment after neoadjuvant chemotherapy
por: Zhang, Meng, et al.
Publicado: (2021)

KIF20A is a Prognostic Marker for Female Patients with Estrogen Receptor-Positive Breast Cancer and Receiving Tamoxifen as Adjuvant Endocrine Therapy
por: Huang, Xuchen, et al.
Publicado: (2023)

The Effect of the Leptin and Leptin Receptor Expression on the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer
por: Kong, Yan, et al.
Publicado: (2019)

Dexrazoxane improves cardiac autonomic function in epirubicin-treated breast cancer patients with type 2 diabetes
por: Sun, Fangyi, et al.
Publicado: (2016)

Mucoepidermoid carcinoma of the breast: Four case reports and review of the literature
por: Cheng, Meng, et al.
Publicado: (2017)

Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab
por: Wang, Xinle, et al.
Publicado: (2019)

Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy
por: Zhu, Jiujun, et al.
Publicado: (2020)

Unsuccessful removal of a totally implantable venous access port caused by thrombosis in the left brachiocephalic vein: A case report
por: Zhang, Xi, et al.
Publicado: (2019)

LncRNA PAPAS may promote triple-negative breast cancer by downregulating miR-34a
por: Kong, Yan, et al.
Publicado: (2019)

Pegylated Liposomal Doxorubicin, Docetaxel, and Trastuzumab as Neoadjuvant Treatment for HER2-Positive Breast Cancer Patients: A Phase II and Biomarker Study
por: Wang, Haoqi, et al.
Publicado: (2022)

An appropriate treatment interval does not affect the prognosis of patients with breast Cancer
por: Gao, Wei, et al.
Publicado: (2022)

Association between the nucleosome footprint of plasma DNA and neoadjuvant chemotherapy response for breast cancer
por: Yang, Xu, et al.
Publicado: (2021)

miR-92b promotes autophagy and suppresses viability and invasion in breast cancer by targeting EZH2
por: Liu, Fei, et al.
Publicado: (2018)

Antibiotics Modulate Chemotherapy Efficacy in Patients with Esophageal Cancer
por: Wu, Chensi, et al.
Publicado: (2020)

Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer
por: Toi, M, et al.
Publicado: (2004)

Neoadjuvant chemotherapy modulates exhaustion of T cells in breast cancer patients
por: Rodríguez, Ivon Johanna, et al.
Publicado: (2023)

Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial
por: Huang, Liang, et al.
Publicado: (2015)

circRNF10 Regulates Tumorigenic Properties and Natural Killer Cell-Mediated Cytotoxicity against Breast Cancer through the miR-934/PTEN/PI3k-Akt Axis
por: Liu, Fei, et al.
Publicado: (2022)

Bootcamp During Neoadjuvant Chemotherapy for Breast Cancer: A Randomized Pilot Trial
por: Rao, Roshni, et al.
Publicado: (2012)

Neoadjuvant targeted therapy for apocrine carcinoma of the breast: A case report
por: Yang, Ping, et al.
Publicado: (2020)

Incidence rate of female breast cancer in urban Shijiazhuang in 2012 and modifiable risk factors
por: Wen, Denggui, et al.
Publicado: (2016)

Combination of pegylated liposomal doxorubicin and docetaxel as neoadjuvant therapy for breast cancer with axillary lymph node metastasis
por: Wang, Li, et al.
Publicado: (2020)

Is there a correlation between miR-301a expression and neoadjuvant chemotherapy efficacy in breast cancer tissue?
por: Deng, Shanshan, et al.
Publicado: (2021)

The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis
por: Chen, Zhe-Ling, et al.
Publicado: (2016)

An Efficient and Simple Method for Collecting Haemolymph of Cerambycidae (Insecta: Coleoptera) Adults
por: Niu, Yiming, et al.
Publicado: (2022)

Effect of tumor-infiltrating lymphocytes depending on the presence of postmastectomy radiotherapy on the prognosis in pT1-2N1M0 breast cancer
por: Zhang, Lina, et al.
Publicado: (2023)

Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer
por: Zhu, Jiujun, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast Cancer
por: Zhu, Xudong, et al.
Publicado: (2019)

CircRNA ZNF609 promotes the growth and metastasis of thyroid cancer in vivo and in vitro by downregulating miR-514a-5p
por: Shi, Ping, et al.
Publicado: (2022)

Survival benefit of neoadjuvant chemotherapy for resectable breast cancer: A meta-analysis
por: Chen, Yan, et al.
Publicado: (2018)

Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer
por: Zhang, Qingyuan, et al.
Publicado: (2018)

ZEB1-Mediated Transcriptional Upregulation of circWWC3 Promotes Breast Cancer Progression through Activating Ras Signaling Pathway
por: Meng, Lingjiao, et al.
Publicado: (2020)

Therapeutic Effect of Trastuzumab in Neoadjuvant-Treated HER2-Positive Breast Cancer with Low Infiltrating Level of Tumor-Infiltrating Lymphocytes
por: Liu, Shiwei, et al.
Publicado: (2020)

Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression
por: Denisov, Evgeny V., et al.
Publicado: (2014)

An Efficient Ensemble Binarized Deep Neural Network on Chip with Perception-Control Integrated †
por: He, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nbtlhs6kea94pcl86gpirnql8c